J. Caleb Snider
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
J. Caleb Snider has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Matthew R. Bersi
Department of Mechanical Engineering & Materials Science, Washington University in St. Louis, St. Louis, MO, USA
5 shared publications - Gabriella Paige Sugerman
Department of Biomedical Engineering, The University of Texas at Austin
2 shared publications - Manuel K. Rausch
Department of Biomedical Engineering, The University of Texas at Austin, Austin, USA
2 shared publications - Marcin Malinowski
Department of Cardiac Surgery, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-007 Katowice, Poland
2 shared publications - Sotirios Kakaletsis
Department of Aerospace Engineering & Engineering Mechanics, The University of Texas at Austin, Austin, TX, USA
2 shared publications Tomasz A. Timek
Division of Cardiothoracic Surgery, Spectrum Health, Grand Rapids, MI, USA
2 shared publications
Latest Publications
- Open Access
Adaptive Immunity Governs Regional Aortic Remodeling in Hypertension via Perivascular Adipose Tissue Plasticity
Hypertension drives heterogeneous aortic remodeling, but the mechanisms underlying regional disparities remain unclear. Here, we demonstrate that adaptive immunity orchestrates spatial differences in vascular dysfunction by modulating perivascular adipose tissue (PVAT) phenotype and immune-metabolic crosstalk. Using angiotensin II (AngII)-infused wild-type (WT) and Rag1 −/− mice lacking T and B cells, we integrated biaxial mechanical testing, bulk transcriptomics, and PVAT analyses. In WT mice, AngII induced pronounced descending thoracic aorta (DTA) remodeling, marked by wall thickening, reduced circumferential stiffness and inflammatory gene upregulation ( Il6 , Ccl2 ). These changes were attenuated in Rag1 −/− mice, implicating T cells in thoracic maladaptation. Conversely, the infrarenal abdominal aorta (IAA) exhibited hypertensive resilience in WT mice but unmasked PPARγ-associated metabolic reprogramming ( Pparg , Adipoq ) in Rag1 −/− mice, suggesting T cells suppress protective abdominal adaptations. PVAT heterogeneity emerged as a key regulator wherein thoracic PVAT (T-PVAT) adopted a pro-inflammatory phenotype (CCL5, TIMP-1) in WT mice, exacerbating DTA damage, while Rag1 −/− mice showed thermogenic plasticity ( Ucp1 upregulation) in abdominal PVAT (A-PVAT). T cell reconstitution restored maladaptive remodeling in Rag1 −/− mice, confirming adaptive immunity’s dual role in promoting thoracic injury and restraining metabolic resilience. This work identifies PVAT as an immune-metabolic switch governing regional susceptibility to vascular remodeling, offering spatially resolved strategies to preserve aortic compliance in hypertensive disease.
Open AccessAdaptive Immunity Governs Regional Aortic Remodeling in Hypertension via Perivascular Adipose Tissue Plasticity
Hypertension drives heterogeneous aortic remodeling, but the mechanisms underlying regional disparities remain unclear. Here, we demonstrate that adaptive immunity orchestrates spatial differences in vascular dysfunction by modulating perivascular adipose tissue (PVAT) phenotype and immune-metabolic crosstalk. Using angiotensin II (AngII)-infused wild-type (WT) and Rag1 −/− mice lacking T and B cells, we integrated biaxial mechanical testing, bulk transcriptomics, and PVAT analyses. In WT mice, AngII induced pronounced descending thoracic aorta (DTA) remodeling, marked by wall thickening, reduced circumferential stiffness and inflammatory gene upregulation ( Il6 , Ccl2 ). These changes were attenuated in Rag1 −/− mice, implicating T cells in thoracic maladaptation. Conversely, the infrarenal abdominal aorta (IAA) exhibited hypertensive resilience in WT mice but unmasked PPARγ-associated metabolic reprogramming ( Pparg , Adipoq ) in Rag1 −/− mice, suggesting T cells suppress protective abdominal adaptations. PVAT heterogeneity emerged as a key regulator wherein thoracic PVAT (T-PVAT) adopted a pro-inflammatory phenotype (CCL5, TIMP-1) in WT mice, exacerbating DTA damage, while Rag1 −/− mice showed thermogenic plasticity ( Ucp1 upregulation) in abdominal PVAT (A-PVAT). T cell reconstitution restored maladaptive remodeling in Rag1 −/− mice, confirming adaptive immunity’s dual role in promoting thoracic injury and restraining metabolic resilience. This work identifies PVAT as an immune-metabolic switch governing regional susceptibility to vascular remodeling, offering spatially resolved strategies to preserve aortic compliance in hypertensive disease.
- 25 December 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 175, 186-198
Remodeling of murine vaginal smooth muscle function with reproductive age and elastic fiber disruption
- 25 December 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 175, 186-198
Remodeling of murine vaginal smooth muscle function with reproductive age and elastic fiber disruption
- 4 October 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 171, 155-165
Untangling the mechanisms of pulmonary arterial hypertension-induced right ventricular stiffening in a large animal model
- 4 October 2023
- Published by Elsevier in Acta Biomaterialia
- Vol. 171, 155-165
Untangling the mechanisms of pulmonary arterial hypertension-induced right ventricular stiffening in a large animal model
- Open Access
Untangling the mechanisms of pulmonary hypertension-induced right ventricular stiffening in a large animal model
Background: Pulmonary arterial hypertension (PHT) is a devastating disease with low survival rates. In PHT, chronic pressure overload leads to right ventricle (RV) remodeling and stiffening; thus, impeding diastolic filling and ventricular function. Multiple mechanisms contribute to RV stiffening, including wall thickening, microstructural disorganization, and myocardial stiffening. The relative importance of each mechanism is unclear. Our objective is to use a large animal model as well as imaging, experimental, and computational approaches to untangle these mechanisms. Methods: We induced PHT in eight sheep via pulmonary artery banding. After eight weeks, the hearts underwent anatomic and diffusion tensor MRI to characterize wall thickening and microstructural disorganization. Additionally, myocardial samples underwent histological and gene expression analyses to quantify compositional changes and mechanical testing to quantify myocardial stiffening. All findings were compared to 12 control animals. Finally, we used computational modeling to disentangle the relative importance of each stiffening mechanism. Results: First, we found that the RVs of PHT animals thickened most at the base and the free wall. Additionally, we found that PHT induced excessive collagen synthesis and microstructural disorganization, consistent with increased expression of fibrotic genes. We also found that the myocardium itself stiffened significantly. Importantly, myocardial stiffening correlated significantly with excess collagen synthesis. Finally, our model of normalized RV pressure-volume relationships predicted that myocardial stiffness contributes to RV stiffening significantly more than other mechanisms. Conclusions: In summary, we found that PHT induces wall thickening, microstructural disorganization, and myocardial stiffening. These remodeling mechanisms were both spatially and directionally dependent. Using modeling, we show that myocardial stiffness is the primary contributor to RV stiffening. Thus, myocardial stiffening may be an important predictor for PHT progression. Given the significant correlation between myocardial stiffness and collagen synthesis, collagen-sensitive imaging modalities may be useful for non-invasively estimating myocardial stiffness and predicting PHT outcomes.
Open AccessUntangling the mechanisms of pulmonary hypertension-induced right ventricular stiffening in a large animal model
Background: Pulmonary arterial hypertension (PHT) is a devastating disease with low survival rates. In PHT, chronic pressure overload leads to right ventricle (RV) remodeling and stiffening; thus, impeding diastolic filling and ventricular function. Multiple mechanisms contribute to RV stiffening, including wall thickening, microstructural disorganization, and myocardial stiffening. The relative importance of each mechanism is unclear. Our objective is to use a large animal model as well as imaging, experimental, and computational approaches to untangle these mechanisms. Methods: We induced PHT in eight sheep via pulmonary artery banding. After eight weeks, the hearts underwent anatomic and diffusion tensor MRI to characterize wall thickening and microstructural disorganization. Additionally, myocardial samples underwent histological and gene expression analyses to quantify compositional changes and mechanical testing to quantify myocardial stiffening. All findings were compared to 12 control animals. Finally, we used computational modeling to disentangle the relative importance of each stiffening mechanism. Results: First, we found that the RVs of PHT animals thickened most at the base and the free wall. Additionally, we found that PHT induced excessive collagen synthesis and microstructural disorganization, consistent with increased expression of fibrotic genes. We also found that the myocardium itself stiffened significantly. Importantly, myocardial stiffening correlated significantly with excess collagen synthesis. Finally, our model of normalized RV pressure-volume relationships predicted that myocardial stiffness contributes to RV stiffening significantly more than other mechanisms. Conclusions: In summary, we found that PHT induces wall thickening, microstructural disorganization, and myocardial stiffening. These remodeling mechanisms were both spatially and directionally dependent. Using modeling, we show that myocardial stiffness is the primary contributor to RV stiffening. Thus, myocardial stiffening may be an important predictor for PHT progression. Given the significant correlation between myocardial stiffness and collagen synthesis, collagen-sensitive imaging modalities may be useful for non-invasively estimating myocardial stiffness and predicting PHT outcomes.
- 21 January 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 143 (13) , 1317-1330
Targeting 5-HT 2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction
Background: Myocardial infarction (MI) induces an intense injury response that ultimately generates a collagen-dominated scar. Although required to prevent ventricular rupture, the fibrotic process is often sustained in a manner detrimental to optimal recovery. Cardiac myofibroblasts are the cells tasked with depositing and remodeling collagen and are a prime target to limit the fibrotic process after MI. Serotonin 2B receptor (5-HT 2B ) signaling has been shown to be harmful in a variety of cardiopulmonary pathologies and could play an important role in mediating scar formation after MI. Methods: We used 2 pharmacological antagonists to explore the effect of 5-HT 2B inhibition on outcomes after MI and characterized the histological and microstructural changes involved in tissue remodeling. Inducible 5-HT 2B ablation driven by Tcf21 MCM and Postn MCM was used to evaluate resident cardiac fibroblast- and myofibroblast-specific contributions of 5-HT 2B , respectively. RNA sequencing was used to motivate subsequent in vitro analyses to explore cardiac fibroblast phenotype. Results: 5-HT 2B antagonism preserved cardiac structure and function by facilitating a less fibrotic scar, indicated by decreased scar thickness and decreased border zone area. 5-HT 2B antagonism resulted in collagen fiber redistribution to thinner collagen fibers that were more anisotropic, enhancing left ventricular contractility, whereas fibrotic tissue stiffness was decreased, limiting the hypertrophic response of uninjured cardiomyocytes. Using a tamoxifen-inducible Cre, we ablated 5-HT 2B from Tcf21 -lineage resident cardiac fibroblasts and saw similar improvements to the pharmacological approach. Tamoxifen-inducible Cre-mediated ablation of 5-HT 2B after onset of injury in Postn -lineage myofibroblasts also improved cardiac outcomes. RNA sequencing and subsequent in vitro analyses corroborate a decrease in fibroblast proliferation, migration, and remodeling capabilities through alterations in Dnajb4 expression and Src phosphorylation. Conclusions: Together, our findings illustrate that 5-HT 2B expression in either cardiac fibroblasts or activated myofibroblasts directly contributes to excessive scar formation, resulting in adverse remodeling and impaired cardiac function after MI.
- 21 January 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 143 (13) , 1317-1330
Targeting 5-HT 2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction
Background: Myocardial infarction (MI) induces an intense injury response that ultimately generates a collagen-dominated scar. Although required to prevent ventricular rupture, the fibrotic process is often sustained in a manner detrimental to optimal recovery. Cardiac myofibroblasts are the cells tasked with depositing and remodeling collagen and are a prime target to limit the fibrotic process after MI. Serotonin 2B receptor (5-HT 2B ) signaling has been shown to be harmful in a variety of cardiopulmonary pathologies and could play an important role in mediating scar formation after MI. Methods: We used 2 pharmacological antagonists to explore the effect of 5-HT 2B inhibition on outcomes after MI and characterized the histological and microstructural changes involved in tissue remodeling. Inducible 5-HT 2B ablation driven by Tcf21 MCM and Postn MCM was used to evaluate resident cardiac fibroblast- and myofibroblast-specific contributions of 5-HT 2B , respectively. RNA sequencing was used to motivate subsequent in vitro analyses to explore cardiac fibroblast phenotype. Results: 5-HT 2B antagonism preserved cardiac structure and function by facilitating a less fibrotic scar, indicated by decreased scar thickness and decreased border zone area. 5-HT 2B antagonism resulted in collagen fiber redistribution to thinner collagen fibers that were more anisotropic, enhancing left ventricular contractility, whereas fibrotic tissue stiffness was decreased, limiting the hypertrophic response of uninjured cardiomyocytes. Using a tamoxifen-inducible Cre, we ablated 5-HT 2B from Tcf21 -lineage resident cardiac fibroblasts and saw similar improvements to the pharmacological approach. Tamoxifen-inducible Cre-mediated ablation of 5-HT 2B after onset of injury in Postn -lineage myofibroblasts also improved cardiac outcomes. RNA sequencing and subsequent in vitro analyses corroborate a decrease in fibroblast proliferation, migration, and remodeling capabilities through alterations in Dnajb4 expression and Src phosphorylation. Conclusions: Together, our findings illustrate that 5-HT 2B expression in either cardiac fibroblasts or activated myofibroblasts directly contributes to excessive scar formation, resulting in adverse remodeling and impaired cardiac function after MI.